ponsored by the Miller School and hosted by the Department of Neurology, the symposium “Neurology Update and Stroke Intensive 2014” will be held February 6-8 from 7 a.m. to 4 p.m. at the Mayfair Hotel, 3000 Florida Avenue, Miami.
News : 2013
The University of Miami Miller School of Medicine has been named part of a national stroke network established by the National Institutes of Health to more quickly translate research discoveries to patients. Recognized for its excellence in the field of stroke prevention and treatment, the Miller School will lead the Miami Regional Coordinating Center (RCC).
Cardiovascular disease and stroke could be slowed down by taking care of your gums by brushing, flossing and regular dental visits. Miller School neurologists were co-authors of a study that shows for the first time that as gum health improves, progression of atherosclerosis slows to a clinically significant degree.
UM President Donna E. Shalala presented Neurology Grand Rounds, “Views on Health Care Reform and the Impact on Academic Medical Centers,” Friday, November 8, in the Gordon Center for Research in Medical Education, Broad-Bussel Auditorium. Ralph L. Sacco, M.D., M.S., professor and Chair of Neurology and the Olemberg Family Chair in Neurological Disorders, invited President Shalala to speak to neurology residents and faculty.
Proteins in a cell are universally synthesized by ribosomes. Mitochondria, the powerhouses of the cell, contain their own ribosomes, which specialize in synthesizing a handful of proteins (8 in yeast, 13 in human cells). These proteins are required for the generation of chemical energy in the form of adenosine triphosphate (ATP) by the process of oxidative phosphorylation.
Miami Mayor Tomas Regalado presented Ralph L. Sacco, M.D., M.S., professor and Chair of Neurology and the Olemberg Family Chair in Neurological Disorders, with a proclamation declaring October 29 as World Stroke Day in Miami at a Miami City Commission meeting.
Mary Bartlett Bunge, Ph.D., professor of cell biology, neurological surgery and neurology at the Univerisity of Miami Miller School of Medicine’s Miami Project to Cure Paralysis, has been elected to the National Academy of Sciences Institute of Medicine, an extraordinary honor that reflects the height of professional achievement and commitment to service in health and medicine.
For the second year, a team from the Department of Neurology Parkinson’s Disease and Movement Disorders Center participated in “Moving Day Miami,” the National Parkinson Foundation’s annual walk to help raise awareness and essential research funds for Parkinson’s disease.
A new drug development grant from the U.S. Department of Defense will allow researchers at the University of Miami Miller School of Medicine to study potential treatments for amyotrophic lateral sclerosis (ALS), a neurological degenerative condition commonly called Lou Gehrig’s disease.
Scientists of the International Multiple Sclerosis Genetics Consortium (IMSGC) have identified an additional 48 genetic variants influencing the risk of developing multiple sclerosis. This work nearly doubles the number of known genetic risk factors and thereby provides additional key insights into the biology of this debilitating neurological condition.
Greater Miami’s firefighters announced their annual Labor Day weekend “Fill the Boot” Drive that benefits the Muscular Dystrophy Association (MDA) with a kick-off event at the Biomedical Research Building last week that showcased the Miller School’s neurological research and featured a testimonial from a grateful patient.
Ralph L. Sacco, M.D., M.S., professor and Chair of Neurology and the Olemberg Family Chair in Neurological Disorders, has been appointed to the NIH’s National Advisory Neurological Disorders and Stroke Council, the principal advisory body to the National Institute of Neurological Disorders and Stroke (NINDS).
A breakthrough Miller School study on mapping the network of small blood vessels in the retina may lead to improved clinical management of central nervous system, systemic and ocular vascular diseases. The study was led by Hong Jiang, M.D., Ph.D., assistant professor of ophthalmology at Bascom Palmer Eye Institute.
A revolutionary brain cancer vaccine clinical trial once limited to patients with newly diagnosed glioblastoma multiforme is now offered to UHealth patients with a recurrent brain tumor. As in the original study, the patient’s own tumor cells are used to develop the vaccine that is designed to target the immune system, offering hope to those with the most common and aggressive form of brain tumor.
A groundbreaking cellular genetics study led by Carlos T. Moraes, Ph.D., professor of neurology and cell biology, opens the door to potential new treatments for mitochondrial diseases that affect the nerves, muscles and vital organs.
The Miami Clinical and Translational Science Institute (CTSI) has awarded grants to two Miller School researchers for its Mentored Translational Research Scholars Program (K12), which helps junior faculty become successful independent investigators
From ischemic heart disease to diabetes to interpersonal violence, the United States fares worse than its economic peers around the world in nearly every major cause of premature death, according to a study published online July 10 in the Journal of the American Medical Association by a global collaborative of scientists that includes three Miller School experts.
The Miller School of Medicine is launching a new Florida Puerto Rico Collaboration to Reduce Stroke Disparities funded by a $3.7 million grant from the National Institutes of Health (NIH). “Our mission is to improve the treatment and prevention of stroke among Hispanics,” said principal investigator Ralph L. Sacco, M.D., M.S., professor and chair of neurology, and Olemberg Family Chair of Neurological Disorders.
Miller School researchers collaborated with an international team to identify a new gene associated with Alzheimer’s disease in African Americans. Published April 10 in the prestigious Journal of the American Medical Association, their study provides new directions for biological, genetic and therapeutic studies of Alzheimer’s disease.
Three Miller School students were recognized at the American Academy of Neurology 2013 Annual Meeting in San Diego. Thomas Hughes is the first Miller School student to be awarded the AAN Minority Scholarship, while Christine Greer received the AAN SIGN (Student Interest Group in Neurology) Scholarship, and Kevin Fu was recognized for his superior work and statistical analysis on the project he shared with Hughes.
Another record crowd came out for this year’s Brain Fair at the Miami Science Museum, organized by University of Miami scientists and colleagues from several other institutions. The free science event drew more than 3,000 children of all ages who learned how the brain works through an array of hands-on activities.
Miller School researchers led by Ralph L. Sacco, M.D., M.S., professor and Chair of Neurology, collaborated on a study that found the virus that causes cold sores, along with other viral or bacterial infections, may be associated with cognitive problems.
The Miller School’s Ralph L. Sacco, M.D., M.S., the first neurologist to serve as president of the national American Heart Association, coauthored the AHA’s new recommendations for policymakers and public health providers to combat heart disease and stroke at the local level.
An international team of researchers that included the Miller School’s Michael Benatar, M.D., Ph.D., associate professor of neurology, has discovered two new genetic causes of a multi-system degenerative disorder that typically affects the brain, muscle and bone, and that also may cause amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.
To cheers, honking horns and loud applause, Roy Roden and his wife Lynn pedaled their bikes to the Schoninger Research Quadrangle on the Miller School campus Friday, completing a 4,500-mile ride that started in Seattle last November to raise awareness and research funds for Parkinson’s disease.
The Board of Trustees of the Evelyn F. McKnight Brain Research Foundation returned to the Miller School of Medicine last week for an update on the Evelyn F. McKnight Brain Institute’s ongoing and new research into the causes and treatment of age-related cognitive disorders of the brain.
The first two stroke patients have been enrolled in a phase 2 clinical trial of a revolutionary new treatment for ischemic stroke being conducted at the University of Miami/Jackson Memorial Hospital. The trial, using a patient’s own bone marrow stem cells, is the first intra-arterial stroke stem cell trial in the U.S., and the two UM/Jackson patients are the first in Florida to participate.